Cleveland Diagnostics has filed a notice of an exempt offering of securities to raise $56,494,419.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Cleveland Diagnostics is raising up to $56,494,419.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Arnon Chait played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Cleveland Diagnostics
Cleveland Diagnostics is developing a breakthrough technology to discover a new class of diagnostics tests with high sensitivity and specificity for many cancers early on, when cancer is still curable.
To learn more about Cleveland Diagnostics, visit http://www.clevelanddx.com/
Contact:
Arnon Chait, Chief Executive Officer
216-432-2700
https://www.linkedin.com/in/arnon-chait-6594701/
SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.